International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

Corneel Coens(European Organisation for Research and Treatment of Cancer), Madeline Pe(European Organisation for Research and Treatment of Cancer), Amylou C. Dueck(Mayo Clinic in Arizona), Jeff A. Sloan(Alliance Data (United States)), Ethan Basch(UNC Lineberger Comprehensive Cancer Center), Melanie Calvert(National Institute for Health Research), Alicyn Campbell(National Patient Safety Foundation), Charles S. Cleeland(The University of Texas MD Anderson Cancer Center), Kim Cocks(Adelphi Group (United Kingdom)), Laurence Collette(European Organisation for Research and Treatment of Cancer), Nancy Devlin(The University of Melbourne), Lien Dorme(European Organisation for Research and Treatment of Cancer), Hans‐Henning Flechtner(University Hospital Magdeburg), Carolyn Gotay(University of British Columbia), Ingolf Griebsch(Boehringer Ingelheim (Germany)), Mogens Grøenvold(University of Copenhagen), Madeleine King(The University of Sydney), Paul G. Kluetz(Center for Drug Evaluation and Research), Michael Koller(University Hospital Regensburg), Daniel C. Malone(University of Arizona), Francesca Martinelli(European Organisation for Research and Treatment of Cancer), Sandra A. Mitchell(National Cancer Institute), Jammbe Musoro(European Organisation for Research and Treatment of Cancer), Daniel O’Connor, Kathy Oliver(Brain Tumour Charity), Elisabeth Piault‐Louis, Martine Piccart(Institut Jules Bordet), Chantal Quinten(European Centre for Disease Prevention and Control), Jaap C. Reijneveld(Amsterdam UMC Location Vrije Universiteit Amsterdam), Christoph Schürmann(Institute for Quality and Efficiency in Health Care), Ashley Wilder Smith(National Cancer Institute), Katherine M Soltys(Health Canada), Martin Taphoorn(Leiden University Medical Center), Galina Velikova(International Society for Quality of Life Research), Andrew Bottomley(European Organisation for Research and Treatment of Cancer)
The Lancet Oncology
January 30, 2020
Cited by 305Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis